Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014
- PMID: 30217156
- PMCID: PMC6137867
- DOI: 10.1186/s12913-018-3529-4
Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014
Abstract
Background: Pneumonia is the leading cause of morbidity and mortality worldwide. Pneumococcal conjugate vaccines have reduced the burden of pneumonia, but data on the current burden of pneumonia and its impact on the healthcare system are needed to inform the development and use of new vaccines and other preventive measures.
Methods: We retrospectively analyzed the frequency of pneumonia in the US during 2008-2014 using data from the MarketScan® Commercial Claims and Encounters database. Frequencies of healthcare utilization related to the index pneumonia episode were calculated using the annual number of enrolled person-years (PY) as the denominator and the number of individuals with pneumonia as the numerator. Pneumonia-associated costs were calculated as mean payment per episode during the 2 years from 2013 to 2014.
Results: The overall annual healthcare utilization rate for pneumonia was 15.1 per 1000 PY and decreased slightly from 2008 to 2014 (from 15.4 to 13.5 per 1000 PY). Most pneumonia-related healthcare utilization was due to office/outpatient visits (10.3 per 1000 PY; 68.3%). Emergency department/urgent care visits (2.5 per 1000 PY; 16.9%) and hospitalizations (2.2 per 1000 PY; 14.8%) contributed less. Pneumonia-related healthcare utilization was highest in children < 5 years (rate per 1000 PY = 29.7 for < 1 year, 47.9 for 1 year, and 39.5 for 2-4 years) and adults > 65 years (45.0 per 1000 PY). The mean cost per pneumonia episode (95% confidence interval) was US$429.1 ($424.8-$433.4) for office/outpatient visits, $1126.9 ($1119.5-$1134.3) for emergency department/urgent care visits, and $10,962.5 ($10,822.8-$11,102.2) for hospitalization.
Conclusions: The burden of pneumonia on the US healthcare system remains substantial. The results presented here can help guide new vaccination strategies and other preventive interventions for reducing the remaining burden of pneumonia.
Keywords: Epidemiology; Healthcare cost; Healthcare utilization; Pneumonia; United States.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
C.A. is an employee of Sanofi, and A.K. and M.H.K. are employees of Sanofi Pasteur. S.T. was paid by Sanofi Pasteur for statistical analyses included in this manuscript.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- 
    - Unicef. Pneumonia claims the lives of the world’s most vulnerable children. 4y. https://data.unicef.org. Accessed 16 Feb 2018.
 
- 
    - US Centers for Disease Control and Prevention. Deaths: final data for 2015. In: National Vital Statistics Reports. Hyattsville: National Center for Health Statistics; 2017;66. https://www.cdc.gov/nchs/data/nvsr/nvsr66/nvsr66_06.pdf.
 
- 
    - Marston BJ, Plouffe JF, File TM, Jr, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The community-based pneumonia incidence study group. Arch Intern Med. 1997;157:1709–1718. doi: 10.1001/archinte.1997.00440360129015. - DOI - PubMed
 
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
         
               
              